Heron Therapeutics
HRTX
HRTX
170 hedge funds and large institutions have $207M invested in Heron Therapeutics in 2025 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 56 increasing their positions, 43 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
4% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 25
1% less funds holding
Funds holding: 171 → 170 (-1)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
170
Holding in Top 10
2
Calls
$520K
Puts
$30K
Top Buyers
| 1 | +$8.55M | |
| 2 | +$3.46M | |
| 3 | +$3.11M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.68M |
| 5 |
Jane Street
New York
|
+$1.42M |
Top Sellers
| 1 | -$5.36M | |
| 2 | -$3.05M | |
| 3 | -$1.93M | |
| 4 |
Morgan Stanley
New York
|
-$1.86M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$1.65M |
